Fusion Pharmaceuticals Inc (FUSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FUSN | NAMS | RXRX | ||
| Company | Fusion Pharmaceuticals Inc | Newamsterdam Pharma Company N.V. | Recursion Pharmaceuticals Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 21.55 | 20.22 | 6.02 | ||
| High | 21.59 | 21.65 | 6.03 | ||
| Low | 21.45 | 19.89 | 5.62 | ||
| Last | 21.55 | 20.12 | 5.75 | ||
| Change | +0.03 | +0.11 | -0.29 | ||
| % Change | +0.14% | +0.55% | -4.80% | ||
| Volume | 6,089,100 | 1,183,300 | 12,353,600 | ||
| 20-Day Average Volume | 945,620 | 678,705 | 7,317,115 | ||
| Previous Close | 21.52 | 20.01 | 6.04 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 21.47 | 21.40 | 6.70 | ||
| 20-Day Raw Stochastic | 80.00% | 40.98% | 4.53% | ||
| 20-Day Relative Strength | 72.24% | 48.86% | 40.37% | ||
| Weighted Alpha | +82.32 | +32.65 | -38.85 | ||
| Today's Opinion | 100% Buy | 48% Buy | 88% Sell | ||
| Previous Opinion | 100% Buy | 48% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 16% Buy | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.33% since 05/24/24 | -19.42% since 11/14/24 | -16.79% since 11/14/24 | ||
| Low | 21.38 on 05/30/24 | 19.59 on 11/20/24 | 5.62 on 11/21/24 | ||
| High | 21.60 on 05/31/24 | 25.32 on 11/18/24 | 6.92 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | +0.47% since 05/03/24 | +5.78% since 10/21/24 | -14.94% since 10/21/24 | ||
| Low | 21.35 on 05/10/24 | 16.51 on 11/01/24 | 5.62 on 11/21/24 | ||
| High | 21.60 on 05/31/24 | 25.32 on 11/18/24 | 8.49 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +79.73% since 03/01/24 | +23.66% since 08/21/24 | -24.54% since 08/21/24 | ||
| Low | 9.09 on 03/14/24 | 15.19 on 09/25/24 | 5.62 on 11/21/24 | ||
| High | 21.60 on 05/31/24 | 25.32 on 11/18/24 | 8.49 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +302.80% since 12/01/23 | +3.29% since 05/21/24 | -39.54% since 05/21/24 | ||
| Low | 4.78 on 12/11/23 | 15.19 on 09/25/24 | 5.62 on 11/21/24 | ||
| High | 21.60 on 05/31/24 | 25.32 on 11/18/24 | 9.99 on 06/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,833,043 | 1,848,644 | 1,731,312 | ||
| Shares Outstanding, K | 85,060 | 92,386 | 286,641 | ||
| Annual Sales | 2,070,000 | 14,090,000 | 44,580,000 | ||
| Annual Net Income | -94,900,000 | -176,940,000 | -328,070,000 | ||
| Last Quarter Sales | 0 | 29,110,000 | 26,080,000 | ||
| Last Quarter Net Income | -28,180,000 | -16,650,000 | -95,840,000 | ||
| 60-Month Beta | -0.69 | -0.01 | 0.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.40 on 05/07/24 | -0.18 on 11/06/24 | -0.34 on 11/06/24 | ||
| Latest Earnings Date | 05/09/24 | 11/06/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||